Reference
FDA. FDA Drug Safety Communication: FDA reporting permanent skin color changes associated with use of Daytrana patch (methylphenidate transdermal system) for treating ADHD. Internet Document : 24 Jun 2015. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm452244.htm
Rights and permissions
About this article
Cite this article
Daytrana patch causes loss of skin colour. Reactions Weekly 1559, 1 (2015). https://doi.org/10.1007/s40278-015-3190-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-3190-1